Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 14, 2025; 31(10): 102393
Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.102393
Table 2 Survival data of 32 cases of oesophageal gastrointestinal stromal tumour, n (%)
Parameter
Variable
Treatment
    Imatinib2 (6.3)
    Wait and see30 (93.7)
Follow-up time
    Mean (mean ± SD)64.69 ± 33.13
    Median (month, range)65.50 (37.75-93.00)
Survival data
    Recurrence3
    GISTs-related deaths0
Survival rates (%)
1-/3-/5-year OS100/100/100
1-/3-/5-year DFS100/90.6/90.6